1. �㶫ʡ����ҽԺƤ����
2. ���ݹ㶫ʡ����ҽԺƤ����

�����Խǻ�������һ�־����Ŵ������Ե�Ƥ���Ŵ��������ٴ�����Ϊ�Ĥ�װߡ���Ӫ��������Ƥ����ɫ֢������˥�ߡ������׸����Լ�����ϵͳ�𺦡�Ŀǰ�о��������䷢��������ij���������ء�����ø��ֵĻ���ͻ��ɵ��¶���ø���ԵĽ��ͣ�ʹ�������̡������������ø���Խ��͡��������̵Ķ���ø��ֵĶ����ػ�����о���չ����һ�����������Խǻ������ķ������ơ�

Dyskeratosis congenita��DC�� is a rare skin disorder with heterogeneity, which is characterized by mucosal leukoplakia, nail dystrophy, abnormal skin pigmentation, bone marrow failure, cancer predisposition and other system damage. Currently, it is revealed that the pathogenesis of DC is related to the shortening of telomere length. Gene mutation of telomerase complex may result in a decline in telomerase activity and shortening of telomere length. This paper presents the advances in researches of telomerase complex genes responsible for reduction in telomerase activity and shortening of telomerase length, which may facilitate further elucidation of DC pathogenesis.

�㶫ʡ�Ƽ��ƻ�������Ŀ

[1] Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenital. British Journal of Haematology.2009,145,164-172. [2] Armanios M, Alder JK, 1 Parry EM,et al. Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging. The American Journal of Human Genetics.2009,85, 823-832. [3] Connor JM,Gatherer D,Gray FC,et al .Assignment of the gene for dyskeratosis congenita to Xq28.Hum.Genet.1986��72��348-351. [4] Heiss NS,Knight SW,Vulliamy TJ,et al.X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.NatGenet.1998, 19(1),32-38. [5] Kannan K, Nelson ADL, Shippen DE. Dyskerin Is a Component of the Arabidopsis Telomerase RNP Required for Telomere Maintenance. Molecular and Cellular Biology.2008,28(7), 2332-2341. [6] Vulliamy TJ, Walne A, Baskaradas A,et al. Mutations in the reverse transcriptase component of telomerase(TERT) in patients with bone marrow failure. Blood Cells, Molecules, and Diseases . 2005, 34,257-263. [7] Hong YD, Pumbo E, Ivanovich J,et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood. 2009,113, 309-316. [8] Marrone A,WalneA, Tamary H,et al. Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenital and Hoyeraal-Hreidarsson syndrome.Blood.2007,110,4198-4205. [9] Vulliamy TJ, Baskaradas A, Mason PJ��et al .Mutations in the reverse transcriptase component of telomerase(TERT)in patients with bone marrow fail��Blood Cells,Molecules,and Diseases. 2005,34,257-263. [10] Walne J, Vulliamy T, Beswick R,et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase associated proteinNOP10.Human Mol Genet. 2007, 16,1619-1629. [11] Savage SA., Giri N, Baerloche GM,et al.TINF2,a Component of the Shelterin Telomere Protection Complex,Is Mutated in Dyskeratosis Congenita.The American Journal of Human Genetics . 2008,82,501-509. [12] Vulliamy T, Beswick R, Kirwan M ,et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenital. PNAS.2008,105(23), 8073-8078. [13] He H, Wang Y, Guo Xl et al. Pot1b Deletion and Telomerase Haploinsufficiency in Mice Initiate an ATR-Dependent DNA Damage Response and Elicit Phenotypes Resembling Dyskeratosis Congenita . Molecular and Cellular Biology. 2009, 29(1),229-240. [14] Walne A J, Vulliamy T, Beswick R,et al. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.BLOOD,.2008 ,112( 9), 3594-3600. [15] Mitchell JR,Wood E,Collins K. A telomerase component is defective in the human disease dyskeratosis congenita.Nature.1999��402,551-555. [16] Savage SA, Alter BP. The role of telomere biology in bone marrow failure and other disorders. Mechanisms of Ageing and Development. 2008,129, 35-47. [17] Hockemeyer D, Palm W, Wang RC,et al. Engineered telomere degradation models dyskeratosis congenital.Genes�} Developmengt. 2008 ,22,1773-1785. [18] Vulliany TJ,Dokal I. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie.2008,90(1):122-130. [19] Calado RT, Regal JA, Hills M��et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. PNAS,2009,106(4),1187-1192. [20] Kirwan M, Beswick R, Vulliamy T,et al. Exogenous TERC alone can enhance proliferative potential,telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.British Journal of Haemotology.2008,144, 771–781.